HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Autor: Zhang T; New York Medical College, Valhalla, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Febres-Aldana CA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Liu Z; Department of Pathology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Dix JM; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Cheng R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Renaissance School of Medicine, Stony Brook University, Stony Brook, New York., Dematteo RG; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York., Lui AJW; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Research UK, University of Cambridge, Cambridge, United Kingdom., Khodos I; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Gili L; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Mattar MS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Lisanti J; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kwong C; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Linkov I; Pathology Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Tipping MJ; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Antitumor Assessment Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Odintsov I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Somwar R; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4701-4713.

Hypoxia Induces Production of L-2-Hydroxyglutarate.

Autor: Intlekofer AM; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Dematteo RG; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Venneti S; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Finley LW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lu C; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Judkins AR; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA., Rustenburg AS; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Grinaway PB; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chodera JD; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cross JR; The Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Thompson CB; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: thompsonc@mskcc.org.

Publikováno v: Cell metabolism [Cell Metab] 2015 Aug 04; Vol. 22 (2), pp. 304-11. Date of Electronic Publication: 2015 Jul 23.

Induction of sarcomas by mutant IDH2.

Autor: Lu C; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, Nafa K, Agaram NP, Cross JR, Khanin R, Mason CE, Healey JH, Lowe SW, Schwartz GK, Melnick A, Thompson CB

Publikováno v: Genes & development [Genes Dev] 2013 Sep 15; Vol. 27 (18), pp. 1986-98.